These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 37511018)
1. Genetic Abnormalities in Extramedullary Multiple Myeloma. McAvera R; Quinn J; Murphy P; Glavey S Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511018 [TBL] [Abstract][Full Text] [Related]
2. Extramedullary disease in multiple myeloma. Bansal R; Rakshit S; Kumar S Blood Cancer J; 2021 Sep; 11(9):161. PubMed ID: 34588423 [TBL] [Abstract][Full Text] [Related]
3. [Research Progress on Multiple Myeloma with Extramedullary Disease]. Wang L; Zhang YZ Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Jun; 24(3):945-8. PubMed ID: 27342539 [TBL] [Abstract][Full Text] [Related]
4. Extramedullary disease in multiple myeloma: a systematic literature review. Bladé J; Beksac M; Caers J; Jurczyszyn A; von Lilienfeld-Toal M; Moreau P; Rasche L; Rosiñol L; Usmani SZ; Zamagni E; Richardson P Blood Cancer J; 2022 Mar; 12(3):45. PubMed ID: 35314675 [TBL] [Abstract][Full Text] [Related]
5. The Role of Marrow Microenvironment in the Growth and Development of Malignant Plasma Cells in Multiple Myeloma. Giannakoulas N; Ntanasis-Stathopoulos I; Terpos E Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33923357 [TBL] [Abstract][Full Text] [Related]
6. Circulating Serum MicroRNA-130a as a Novel Putative Marker of Extramedullary Myeloma. Besse L; Sedlarikova L; Kryukov F; Nekvindova J; Radova L; Slaby O; Kuglik P; Almasi M; Penka M; Krejci M; Adam Z; Pour L; Sevcikova S; Hajek R PLoS One; 2015; 10(9):e0137294. PubMed ID: 26389804 [TBL] [Abstract][Full Text] [Related]
7. Proteomic analysis of the bone marrow microenvironment in extramedullary multiple myeloma patients. Gregorova J; Vychytilova-Faltejskova P; Kramarova T; Knechtova Z; Almasi M; Stork M; Pour L; Kohoutek J; Sevcikova S Neoplasma; 2022 Mar; 69(2):412-424. PubMed ID: 35037760 [TBL] [Abstract][Full Text] [Related]
8. Genetic Basis of Extramedullary Plasmablastic Transformation of Multiple Myeloma. Liu Y; Jelloul F; Zhang Y; Bhavsar T; Ho C; Rao M; Lewis NE; Cimera R; Baik J; Sigler A; Sen F; Yabe M; Roshal M; Landgren O; Dogan A; Xiao W Am J Surg Pathol; 2020 Jun; 44(6):838-848. PubMed ID: 32118627 [TBL] [Abstract][Full Text] [Related]
9. Cytogenetic and survival analysis in 315 multiple myeloma patients; five with orbital and eight with extramedullary disease. Tucker SM; Zaihra T Orbit; 2023 Dec; 42(6):603-611. PubMed ID: 36697375 [TBL] [Abstract][Full Text] [Related]
11. Identification of long noncoding RNA Chen T; Sun Z; Cui Y; Ji J; Li Y; Qu X Hematology; 2023 Dec; 28(1):2164449. PubMed ID: 36657019 [TBL] [Abstract][Full Text] [Related]
12. Extramedullary multiple myeloma. Weinstock M; Ghobrial IM Leuk Lymphoma; 2013 Jun; 54(6):1135-41. PubMed ID: 23210572 [TBL] [Abstract][Full Text] [Related]
13. Features of extramedullary disease of multiple myeloma: high frequency of p53 deletion and poor survival: a retrospective single-center study of 834 cases. Deng S; Xu Y; An G; Sui W; Zou D; Zhao Y; Qi J; Li F; Hao M; Qiu L Clin Lymphoma Myeloma Leuk; 2015 May; 15(5):286-91. PubMed ID: 25640025 [TBL] [Abstract][Full Text] [Related]
14. Development of extramedullary myeloma in the era of novel agents: no evidence of increased risk with lenalidomide-bortezomib combinations. Varga C; Xie W; Laubach J; Ghobrial IM; O'Donnell EK; Weinstock M; Paba-Prada C; Warren D; Maglio ME; Schlossman R; Munshi NC; Raje N; Weller E; Anderson KC; Mitsiades CS; Richardson PG Br J Haematol; 2015 Jun; 169(6):843-50. PubMed ID: 26032514 [TBL] [Abstract][Full Text] [Related]
15. Liquid extramedullary disease in multiple myeloma strongly predicts a poor prognosis and is associated with bortezomib resistance gene upregulation. Ji J; Guo R; Ma J; Cui Y; Li Y; Sun Z; Li J; Fan L; Qu X Clin Chim Acta; 2023 Aug; 548():117497. PubMed ID: 37479009 [TBL] [Abstract][Full Text] [Related]
16. Elotuzumab for the treatment of extramedullary myeloma: a retrospective analysis of clinical efficacy and SLAMF7 expression patterns. Danhof S; Rasche L; Mottok A; Steinmüller T; Zhou X; Schreder M; Kilian T; Strifler S; Rosenwald A; Hudecek M; Einsele H; Gerhard-Hartmann E Ann Hematol; 2021 Jun; 100(6):1537-1546. PubMed ID: 33575947 [TBL] [Abstract][Full Text] [Related]
17. New insights into role of microenvironment in multiple myeloma. Tricot GJ Int J Hematol; 2002 Aug; 76 Suppl 1():334-6. PubMed ID: 12430876 [TBL] [Abstract][Full Text] [Related]
18. Incidence and clinical features of extramedullary multiple myeloma in patients who underwent stem cell transplantation. Weinstock M; Aljawai Y; Morgan EA; Laubach J; Gannon M; Roccaro AM; Varga C; Mitsiades CS; Paba-Prada C; Schlossman R; Munshi N; Anderson KC; Richardson PP; Weller E; Ghobrial IM Br J Haematol; 2015 Jun; 169(6):851-8. PubMed ID: 25833301 [TBL] [Abstract][Full Text] [Related]
19. Association of increased microvessel density with skeletal extramedullary disease relapse in multiple myeloma patients who have skeletal extramedullary disease at diagnosis. Yang JZ; Wu XD; Meng JB; Zhang JQ; Sun LX Pathol Res Pract; 2018 Oct; 214(10):1694-1699. PubMed ID: 30196985 [TBL] [Abstract][Full Text] [Related]
20. DNA Barcoding Reveals Habitual Clonal Dominance of Myeloma Plasma Cells in the Bone Marrow Microenvironment. Hewett DR; Vandyke K; Lawrence DM; Friend N; Noll JE; Geoghegan JM; Croucher PI; Zannettino ACW Neoplasia; 2017 Dec; 19(12):972-981. PubMed ID: 29091798 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]